galactose has been researched along with Kawasaki Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burns, JC; Choudhury, BP; Franco, A; Hibberd, ML; Hoang, LT; Kanda, Y; Kanegaye, JT; Naidu, NN; Ogata, S; Shimizu, C; Touma, R; Tremoulet, AH; Varki, A | 1 |
1 other study(ies) available for galactose and Kawasaki Disease
Article | Year |
---|---|
Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.
Topics: B-Lymphocytes; beta-D-Galactoside alpha 2-6-Sialyltransferase; Case-Control Studies; Cell Line; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Fucose; Galactose; Glycosylation; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous Lymph Node Syndrome; N-Acetylneuraminic Acid; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Sialyltransferases; Solubility; Treatment Outcome | 2013 |